Nissan Medical Industries Ltd (TLV:NISA)
1,069.00
0.00 (0.00%)
Apr 2, 2025, 5:24 PM IDT
Nissan Medical Industries Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 15.72 | 24.86 | 19.33 | 40.08 | 48.56 | Upgrade
|
Short-Term Investments | 1.58 | 0.19 | 0.18 | 0.07 | 0.29 | Upgrade
|
Cash & Short-Term Investments | 17.29 | 25.05 | 19.51 | 40.16 | 48.84 | Upgrade
|
Cash Growth | -30.97% | 28.42% | -51.42% | -17.79% | 115.59% | Upgrade
|
Accounts Receivable | 71.87 | 92.16 | 120.09 | 98.57 | 83.6 | Upgrade
|
Other Receivables | 8.63 | 19.91 | 4.27 | 2.9 | 5.67 | Upgrade
|
Receivables | 90.07 | 112.07 | 124.36 | 101.48 | 89.26 | Upgrade
|
Inventory | 169.25 | 114.95 | 106.54 | 106.12 | 56.55 | Upgrade
|
Prepaid Expenses | - | 1.43 | 2.31 | 1.3 | 1.16 | Upgrade
|
Other Current Assets | - | 2.44 | 4.09 | 5.82 | - | Upgrade
|
Total Current Assets | 276.61 | 255.94 | 256.8 | 254.86 | 195.82 | Upgrade
|
Property, Plant & Equipment | 379.99 | 399.4 | 403.18 | 380.08 | 403.26 | Upgrade
|
Long-Term Investments | 15.09 | 14.4 | 36.13 | 35.55 | 41.89 | Upgrade
|
Goodwill | 35.24 | 35.24 | 35.24 | 59.04 | 59.04 | Upgrade
|
Other Intangible Assets | 0.94 | 1 | 0.87 | 0.51 | 0.51 | Upgrade
|
Other Long-Term Assets | - | - | 3.9 | - | - | Upgrade
|
Total Assets | 707.88 | 705.98 | 736.12 | 730.04 | 700.51 | Upgrade
|
Accounts Payable | 85.63 | 78.37 | 84.17 | 73.74 | 62.81 | Upgrade
|
Accrued Expenses | - | - | 13.02 | 16.72 | 17.29 | Upgrade
|
Short-Term Debt | 145.15 | 58.21 | 51.07 | 34.9 | 39.42 | Upgrade
|
Current Portion of Long-Term Debt | - | 56.68 | 64.35 | 58.77 | 70.68 | Upgrade
|
Current Portion of Leases | 5 | 5.94 | 3.99 | 3.68 | 3 | Upgrade
|
Current Income Taxes Payable | 0.71 | 3.18 | 2.12 | 2.64 | 1.96 | Upgrade
|
Other Current Liabilities | 13.58 | 18.79 | - | - | - | Upgrade
|
Total Current Liabilities | 250.07 | 221.17 | 218.71 | 190.44 | 195.15 | Upgrade
|
Long-Term Debt | 45.76 | 69 | 123.25 | 133.74 | 118.22 | Upgrade
|
Long-Term Leases | 6.59 | 8.43 | 8.42 | 9.75 | 9.34 | Upgrade
|
Long-Term Deferred Tax Liabilities | 45.3 | 47.46 | 48.56 | 44 | 46.34 | Upgrade
|
Total Liabilities | 353.1 | 351.2 | 404.02 | 386.02 | 376.59 | Upgrade
|
Common Stock | 14.13 | 14.13 | 14.13 | 14.13 | 14.13 | Upgrade
|
Additional Paid-In Capital | 27.24 | 27.24 | 27.24 | 27.24 | 27.24 | Upgrade
|
Retained Earnings | 199.12 | 198.09 | 192.72 | 231.78 | 205.16 | Upgrade
|
Treasury Stock | -1.28 | -1.28 | -1.28 | -1.28 | -1.28 | Upgrade
|
Comprehensive Income & Other | -8.98 | -9.51 | -17.42 | -43.96 | -35.85 | Upgrade
|
Total Common Equity | 230.24 | 228.68 | 215.41 | 227.92 | 209.41 | Upgrade
|
Minority Interest | 124.54 | 126.11 | 116.69 | 116.1 | 114.51 | Upgrade
|
Shareholders' Equity | 354.78 | 354.79 | 332.1 | 344.02 | 323.92 | Upgrade
|
Total Liabilities & Equity | 707.88 | 705.98 | 736.12 | 730.04 | 700.51 | Upgrade
|
Total Debt | 202.5 | 198.26 | 251.08 | 240.84 | 240.66 | Upgrade
|
Net Cash (Debt) | -185.21 | -173.21 | -231.57 | -200.69 | -191.81 | Upgrade
|
Net Cash Per Share | -20.38 | -19.07 | -25.49 | -22.09 | -21.12 | Upgrade
|
Filing Date Shares Outstanding | 8.58 | 9.08 | 9.08 | 9.08 | 9.08 | Upgrade
|
Total Common Shares Outstanding | 8.58 | 9.08 | 9.08 | 9.08 | 9.08 | Upgrade
|
Working Capital | 26.54 | 34.78 | 38.09 | 64.42 | 0.66 | Upgrade
|
Book Value Per Share | 26.84 | 25.18 | 23.71 | 25.09 | 23.05 | Upgrade
|
Tangible Book Value | 194.06 | 192.43 | 179.29 | 168.38 | 149.87 | Upgrade
|
Tangible Book Value Per Share | 22.62 | 21.18 | 19.74 | 18.54 | 16.50 | Upgrade
|
Machinery | - | 650.17 | 628.1 | 570.04 | 577.02 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.